Shopping Cart 0
Cart Subtotal
USD 0

Tetra Discovery Partners LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Tetra Discovery Partners LLC (Tetra Discovery) is a drug development company that researches and develops pharmaceutical drugs based on phosphodiesterase (PDE) sub-type inhibitors for neuroscience and non-neuroscience disorders. The company uses structure-guided drug design chemistry approach to discover allosteric inhibitors of phosphodiesterase 4 subtypes such as PDE4B and PDE4D. Its PDE4B drug is developed for treating various neuroinflammation and traumatic brain injury. Tetra Discovery also offers drugs for the treatment of depression and schizophrenia, Alzheimer's disease, other dementias, traumatic brain injury, psychiatric diseases, and neurodevelopmental disorders. The company partners with various universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system. Tetra Discovery is headquartered in Grand Rapids, Michigan, the US.

Tetra Discovery Partners LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Tetra Discovery Partners Raises USD6 Million in Venture Financing 10

Tetra Discovery Partners Raises USD5 Million in Series A Venture Financing 11

Tetra Discovery Partners Raises USD4.3 Million in Venture Financing 12

Tetra Discovery Raises USD1 Million in Venture Financing 13

Tetra Discovery Raises Funds through Venture Financing 14

Tetra Discovery Raises USD0.3 Million in Venture Financing 15

Tetra Discovery Raises USD 1 Million In Seed Financing 16

Partnerships 17

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 17

Tetra Discovery Partners LLC-Key Competitors 18

Tetra Discovery Partners LLC-Key Employees 19

Tetra Discovery Partners LLC-Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Corporate Communications 21

Jan 17, 2017: Tetra Discovery Partners appoints vice president of clinical operations 21

Product News 22

01/17/2017: Tetra Discovery Partners Appoints Richard Erwin as Vice President, Clinical Operations 22

Product Approvals 23

Apr 03, 2018: FDA Grants Orphan Drug Designation for Tetra Discovery Partners BPN14770 for the Treatment of Fragile X Syndrome 23

Clinical Trials 24

Mar 15, 2018: Tetra Discovery Partners Announces FDA Clearance of IND for Phase 2 Trial of BPN14770 in Fragile X Syndrome 24

Nov 07, 2017: New Preclinical Research Suggests Utility of Tetra Discovery Partners' BPN14770 to Provide Therapeutic Benefit in Fragile X Syndrome 25

Nov 06, 2017: Tetra Discovery Partners Research Supports Ability of Novel Selective PDE4D Inhibitor, BPN14770, to Improve Memory and Cognition 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Key Facts 2

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tetra Discovery Partners LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Tetra Discovery Partners Raises USD6 Million in Venture Financing 10

Tetra Discovery Partners Raises USD5 Million in Series A Venture Financing 11

Tetra Discovery Partners Raises USD4.3 Million in Venture Financing 12

Tetra Discovery Raises USD1 Million in Venture Financing 13

Tetra Discovery Raises Funds through Venture Financing 14

Tetra Discovery Raises USD0.3 Million in Venture Financing 15

Tetra Discovery Raises USD 1 Million In Seed Financing 16

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 17

Tetra Discovery Partners LLC, Key Competitors 18

Tetra Discovery Partners LLC, Key Employees 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Tetra Discovery Partners LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.